S

Scioderm, Inc., an Amicus Therapeutics Company

2 employees

Scioderm, a clinical stage pharmaceutical company, develops topical products for the treatment of chronic skin diseases.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Pharmaceutical
Epidermolysis Bullosa (EB)
Health Care

Date founded

2012

Funding rounds raised

Total raised

$20M

from 2 investors over 2 rounds

S

Scioderm, Inc., an Amicus Therapeutics Company raised $20M on December 18, 2014

Investors: Redmile Group

S

Scioderm, Inc., an Amicus Therapeutics Company raised $16M on April 26, 2013

Investors: Morgenthaler

FAQ